In December 2025, Lilly announced that it would lower the price of Zepbound (tirzepatide) single-dose vials
Z79.4 and Type 2 Diabetes (E11.-): A Mandatory Pairing The ICD-10-CM Official Guidelines for Coding and Reporting (FY 2026), issued by CMS and NCHS, are explicit: when a patients diabetes is classified under E11.- (Type 2 diabetes mellitus) and that patient is on long-term insulin, the coder must assign ICD-10 Code Z79.4 as an additional code
It is always best to consult with your healthcare provider before starting GLP, especially if you are taking other medications or have any existing health conditions
This inherent stability means it is somewhat more robust than larger, more complex peptides under handling conditions
However, theres a concerning rise in the use of unapproved, compounded GLP-1 drugs, which pose significant health risks
Reducing the release of glucose from the liver, which can help to lower blood sugar levels